Zydus to launch Oxemia (Desidustat) a treatment for Anemia in patients with Chronic Kidney Disease (CKD)
Oxemia TM (Desidustat) is a breakthrough treatment for Anemia associated with Chronic Kidney Disease (CKD) in ...
Read more
Tag: zydus
Cadila Healthcare Limited is now Zydus Lifesciences Limited
The Zydus group announced its new brand identity with the listed entity of the group Cadila ...
Read more
Zydus receives final approval from USFDA for Dapagliflozin Tablets
Zydus has received final approval from the USFDA to market Dapagliflozin Tablets in the strengths of ...
Read more
Zydus gets 180 days shared exclusivity for Roflumilast Tablets
Zydus’ U.S. subsidiary Zydus Pharmaceuticals (USA) Inc. has received final approval from the USFDA to market ...
Read more
Zydus Cadila receives tentative approval from USFDA for Osimertinib Tablets
Zydus Cadila has received tentative approval from the USFDA to market Osimertinib Tablets in the strengths ...
Read more
Zydus Cadila receives final approval from USFDA for Fluphenazine Hydrochloride Tablets
Zydus Cadila has received final approval from the USFDA to market Fluphenazine Hydrochloride Tablets in the ...
Read more
Zydus to undertake clinical trials for monoclonal antibodies cocktail for COVID infection
Zydus seeks DCGI approval to undertake clinical trials for monoclonal antibodies cocktail that can neutralise COVID ...
Read more
Zydus and TLC sign agreement to market Liposomal Amphotericin B in India
Zydus and TLC, a specialty pharmaceutical company in Taiwan, today announced the signing of a license ...
Read more
Zydus launches world’s first biosimilar Antibody Drug Conjugate of Trastuzumab Emtansine
The therapy will be priced at nearly 80% less than the currently available option in the ...
Read more
Sharvil Patel – Driving the next growth phase of Zydus
Sharvil Patel is the joint Managing Director of Zydus Cadila Healthcare Limited which is India’s fourth-largest ...
Read more